Wellfully Ltd
ASX:WFL
Wellfully Ltd
ASX:WFL
Price:
0.003 AUD
Market Closed
Updated:
May 5, 2024
Wellfully Ltd
Net Income (Common)
|
Wellfully Ltd
Net Income (Common) Peer Comparison
Comparables:
MYX
NEU
BOT
PBP
C
CU6
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Wellfully Ltd
ASX:WFL
|
Net Income (Common)
-AU$1.3m
|
CAGR 3-Years
39%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-1%
|
|
|
Mayne Pharma Group Ltd
ASX:MYX
|
Net Income (Common)
AU$117.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Neuren Pharmaceuticals Ltd
ASX:NEU
|
Net Income (Common)
AU$157.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
120%
|
CAGR 10-Years
N/A
|
|
|
Botanix Pharmaceuticals Ltd
ASX:BOT
|
Net Income (Common)
-AU$14.6m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-24%
|
|
|
Probiotec Ltd
ASX:PBP
|
Net Income (Common)
AU$8.7m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
21%
|
|
C
|
Clarity Pharmaceuticals Ltd
ASX:CU6
|
Net Income (Common)
-AU$24.6m
|
CAGR 3-Years
-52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Wellfully Ltd's Net Income (Common)?
Net Income (Common)
-1.3m
AUD
-1.3m
AUD
Based on the financial report for Dec 31, 2023, Wellfully Ltd's Net Income (Common) amounts to -1.3m AUD.
What is Wellfully Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
-1%
-1%
Over the last year, the Net Income (Common) growth was 83%. The average annual Net Income (Common) growth rates for Wellfully Ltd have been 39% over the past three years , 8% over the past five years , and -1% over the past ten years .
You don't have any saved screeners yet
